List of SBIR/STTR awards granted to Medosome Biotec, LLC
Medosome Biotec, LLCName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase II contract was awarded to Medosome Biotec, LLC in June, 2020 for $993,274.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42HD097911-02 | Phase II | 993,274 | June 1, 2020 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in May, 2019 for $223,899.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42HD097911-01A1 | Phase I | 223,899 | May 17, 2019 | |||||||
A SBIR Phase II contract was awarded to Medosome Biotec, LLC in July, 2021 for $834,451.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK112540-02 | Phase II | 834,451 | July 20, 2021 | |||||||
A STTR Phase II contract was awarded to Medosome Biotec, LLC in July, 2022 for $999,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42AI122855-02A1 | Phase II | 999,999 | July 20, 2022 | |||||||
A SBIR Phase I contract was awarded to Medosome Biotec, LLC in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL149554-01 | Phase I | 225,000 | September 19, 2019 | |||||||
A STTR Phase II contract was awarded to Medosome Biotec, LLC in July, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42HD089804-04 | Phase II | 1,000,000 | July 14, 2020 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DK123953-01 | Phase I | 225,000 | September 17, 2019 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in September, 2016 for $224,978.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42HD089804-01 | Phase I | 224,978 | September 14, 2016 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in August, 2016 for $294,094.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI122735-01 | Phase I | 294,094 | August 9, 2016 | |||||||
A SBIR Phase I contract was awarded to Medosome Biotec, LLC in April, 2017 for $232,433.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK112540-01A1 | Phase I | 232,433 | April 1, 2017 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in August, 2016 for $224,463.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AR068158-01A1 | Phase I | 224,463 | August 1, 2016 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in April, 2017 for $223,899.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HD092133-01 | Phase I | 223,899 | April 1, 2017 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in March, 2016 for $253,244.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI122855-01A1 | Phase I | 253,244 | March 15, 2016 | |||||||
A STTR Phase II contract was awarded to Medosome Biotec, LLC in July, 2017 for $1,488,962.0 USD from the U.S. Department of Health & Human Services. | STTR | 4R42HD089804-02 | Phase II | 1,488,962 | July 1, 2017 | |||||||
A STTR Phase I contract was awarded to Medosome Biotec, LLC in September, 2015 for $217,801.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41NS095475-01 | Phase I | 217,801 | September 30, 2015 | |||||||
A SBIR Phase I contract was awarded to Medosome Biotec, LLC in September, 2015 for $122,439.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43FD005349-01 | Phase I | 122,439 | September 15, 2015 | |||||||
A SBIR Phase I contract was awarded to Medosome Biotec, LLC in August, 2023 for $325,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR004525-01 | Phase I | 325,000 | August 1, 2023 |
